MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
5.57
+0.12
+2.20%
Opening 13:16 11/04 EST
OPEN
5.46
PREV CLOSE
5.45
HIGH
5.76
LOW
5.46
VOLUME
145.68K
TURNOVER
--
52 WEEK HIGH
14.75
52 WEEK LOW
3.888
MARKET CAP
144.62M
P/E (TTM)
-1.0902
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INO last week (1028-1101)?
Weekly Report · 1d ago
Earnings week ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and more
Seeking Alpha · 1d ago
Warning: INO is at high risk of performing badly
Seeking Alpha · 1d ago
Weekly Report: what happened at INO last week (1021-1025)?
Weekly Report · 10/28 09:26
Reported Earlier, 'New Mpox Variant Detected In Germany: Health Authority' - The Economic Times
Benzinga · 10/22 15:08
Inovio’s INO-3107 shows efficacy in recurrent respiratory papillomatosis
TipRanks · 10/21 12:10
INOVIO Presents Data on INO-3107's Immune Response Against HPV-6 and HPV-11
Benzinga · 10/21 12:03
INOVIO PHARMACEUTICALS INC - 81% OF PATIENTS EXPERIENCED FEWER SURGICAL INTERVENTIONS POST-TREATMENT WITH INO-3107
Reuters · 10/21 12:00
More
About INO
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.